Poor Seizure Control Among Children Attending a Tertiary Hospital in South Western Uganda - A Retrospective Study

Jane Namusisi1,2, Stella Kyoyagala1, Josephine Nantongo2

  • 1Department of Pediatrics and Child Health, Mbarara University of Science and Technology (MUST), Mbarara, Uganda.

Insights

Seizure control in children with epilepsy (CWE) on anti-seizure medications (ASMs) is poor in low-resource settings. Comorbidities, birth asphyxia history, and adolescence are linked to poor seizure control in these children.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Management
  • Global Health

Background:

  • Seizure control in children with epilepsy (CWE) on anti-seizure medications (ASMs) is a significant challenge, particularly in low-resource settings.
  • Uncontrolled seizures in CWE are associated with increased morbidity, mortality, reduced quality of life, and heightened stigma.

Purpose of the Study:

  • To determine the seizure control status among children with epilepsy (CWE) receiving anti-seizure medications (ASMs) at Mbarara Regional Referral Hospital (MRRH).
  • To identify factors associated with poor seizure control in this pediatric population.

Main Methods:

  • A retrospective chart review of 112 medical records of CWE receiving ASMs for at least six months was conducted.
  • Caregiver interviews (physical or telephone) were used to ascertain current seizure control status.

Main Results:

  • Poor seizure control was observed in 60.4% of the 112 enrolled participants.
  • Factors significantly associated with poor seizure control included comorbidities (AOR 3.2), a history of birth asphyxia (AOR 17.8), and being an adolescent (AOR 6.8).

Conclusions:

  • Seizure control among children with epilepsy on ASMs at MRRH remains suboptimal.
  • Interventions to improve seizure control and optimize ASM treatment are crucial, especially for children with comorbidities, a history of birth asphyxia, and adolescents.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
235
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
492
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
233